-
Taxonomy & unit
-
us-gaap: shares
-
Description
-
The average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.
-
Summary
-
Cadrenal Therapeutics, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Diluted history and growth rate from Q1 2022 to Q2 2025.
- Cadrenal Therapeutics, Inc. Weighted Average Number of Shares Outstanding, Diluted for the quarter ending June 30, 2025 was 1.96M shares, a 83.8% increase year-over-year.
- Cadrenal Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2024 was 1.22M shares, a 35.6% increase from 2023.
- Cadrenal Therapeutics, Inc. annual Weighted Average Number of Shares Outstanding, Diluted for 2023 was 899K shares, a 88.6% decline from 2022.
Weighted Average Number of Shares Outstanding, Diluted, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Diluted, YoY Quarterly Growth (%)